Patient Voice Platforms Making the Biggest Difference In 2026: Glaucoma
Glaucoma is the subspecialty where “patient voice platforms” arguably deliver the greatest real-world impact because the clinical challenge is less about short-term decisional points and more about sustained behaviour over years: attending lifelong monitoring, instilling drops correctly, persisting with treatment despite limited symptoms, and navigating escalation to laser or surgery. Those are precisely the domains where organised patient communities, education hubs, and adherence support add value. This is particularly relevant in the context of persistent global vision impairment burden and health system emphasis on people-centred eye care, which explicitly positions community engagement and empowerment as part of delivery, not an optional adjunct.
